Zhong Xu Selected Research

Zhong Xu Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 12/2004
8	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 07/2011
6	Stomach Neoplasms (Stomach Cancer) 12/2021 - 12/2008
5	Carcinogenesis 01/2020 - 10/2014
3	Parkinson Disease (Parkinson's Disease) 01/2023 - 01/2018
3	Restless Legs Syndrome (Restless Legs) 10/2019 - 01/2018
3	Infections 03/2014 - 05/2009
2	Cognitive Dysfunction 02/2024 - 01/2022
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2012
2	Neuroblastoma 11/2020 - 02/2020
2	Lymphatic Metastasis 01/2020 - 12/2014
2	Necrosis 11/2019 - 11/2011
2	Cholangiocarcinoma 01/2018 - 12/2017
2	Pneumonia (Pneumonitis) 01/2015 - 10/2006
2	Carcinoma (Carcinomatosis) 12/2014 - 12/2008
2	Inflammation (Inflammations) 09/2011 - 10/2006
1	Amyloid Plaque 02/2024
1	Dyskinesias (Dyskinesia) 12/2023
1	Liver Neoplasms (Liver Cancer) 12/2023
1	Stroke (Strokes) 06/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 06/2023
1	Thrombosis (Thrombus) 06/2023
1	Myocardial Infarction 06/2023
1	Sleep Wake Disorders 01/2023
1	Orthostatic Hypotension (Postural Hypotension) 01/2022
1	Adenocarcinoma 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Benign Paroxysmal Positional Vertigo 01/2019
1	Critical Illness (Critically Ill) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2018
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 10/2017
1	Liver Cell Adenoma (Hepatocellular Adenoma) 11/2016
1	Cardiomyopathies (Cardiomyopathy) 04/2015
1	Hypertrophy 04/2015

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 12/2023 - 12/2008
4	MicroRNAs (MicroRNA)IBA 01/2021 - 03/2014
4	Small Interfering RNA (siRNA)IBA 01/2020 - 11/2009
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2009
3	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2014
3	CateninsIBA 01/2022 - 11/2016
3	Mechanistic Target of Rapamycin Complex 2IBA 11/2019 - 12/2017
2	Therapeutic UsesIBA 12/2023 - 07/2011
2	Uric Acid (Urate)IBA 01/2023 - 01/2019
2	Long Noncoding RNAIBA 12/2021 - 01/2021
2	Phosphotransferases (Kinase)IBA 11/2019 - 12/2017
2	sapanisertibIBA 11/2019 - 12/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2019 - 12/2017
2	Enterotoxin ReceptorsIBA 11/2009 - 12/2008
1	Amyloid (Amyloid Fibrils)IBA 02/2024
1	Trimetazidine (Vastarel)IBA 12/2023
1	Sorafenib (BAY 43-9006)FDA Link 12/2023
1	omega-Chloroacetophenone (Mace)IBA 06/2023
1	AntioxidantsIBA 01/2023
1	hydroxide ionIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2020
1	Cell-Free Nucleic AcidsIBA 02/2020
1	Neuropilin-1IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Zinc Finger E-box-Binding Homeobox 1IBA 01/2020
1	VimentinIBA 11/2019
1	Sirolimus (Rapamycin)FDA Link 11/2019
1	TOR Serine-Threonine KinasesIBA 11/2019
1	Cadherins (E-Cadherin)IBA 11/2019
1	Ferritins (Ferritin)IBA 10/2019
1	micaIBA 01/2019
1	IronIBA 01/2019
1	Focal Adhesion Protein-Tyrosine KinasesIBA 12/2018
1	Dasatinib (BMS 354825)FDA Link 12/2018
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2018
1	insulin-like growth factor binding protein-related protein 1IBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	Fibroblast Growth Factor-23IBA 01/2018
1	Cystatin CIBA 01/2018
1	Gemcitabine FDA Link 12/2017
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2017
1	ZeranolIBA 10/2017
1	Estrogens (Estrogen)FDA Link 10/2017
1	Phytoestrogens (Phytoestrogen)IBA 10/2017
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 11/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	Phosphatidic Acids (Phosphatidic Acid)IBA 04/2015
1	Peptide Hydrolases (Proteases)FDA Link 04/2015
1	Myosins (Myosin)IBA 04/2015
1	ZincIBA 04/2015
1	Complementary DNA (cDNA)IBA 04/2015
1	Carrier Proteins (Binding Protein)IBA 04/2015
1	Metalloproteases (Metalloproteinases)IBA 04/2015
1	MyostatinIBA 04/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015
1	Nucleic AcidsIBA 07/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2011
1	salicylhydroxamic acid (SHAM)IBA 09/2011

Therapy/Procedure

3	Therapeutics 01/2018 - 10/2006
1	Percutaneous Coronary Intervention 06/2023
1	Stents 06/2023
1	Ambulatory Care (Outpatient Care) 06/2023
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 12/2017